I'm thinking this company as great as its growth will be it will end up like other biotechs like to a minor degree like RHT where is never will end up making a decent profit for shareholders because the high cost of technical staff will keep balance sheet in the red for years. They end up being a publically funded co-op for staff. Look how much time was spent in Annual report on self-promotion. Sp probably will keep rising for now but with such losses continuing into future there are better buys on asx. Please prove me wrong someone.lol
Ann: Alcidion to present at Health Informatics New Zealand (HiNZ)-ALC.AX, page-3
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
12.0¢ |
Change
0.005(4.35%) |
Mkt cap ! $161.1M | |||
| Open | High | Low | Value | Volume |
| 12.0¢ | 12.0¢ | 11.0¢ | $68.27K | 592.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 16 | 709741 | 11.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.0¢ | 661501 | 8 |
View Market Depth
| Last trade - 16.10pm 01/08/2025 (20 minute delay) ? |
| ALC (ASX) Chart |